LUND, Sweden, March 3, 2025 /PRNewswire/ -- Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the results of its CLARITI study have been selected for a distinguished plenary presentation at the upcoming Digestive Disease Week® (DDW) 2025...
Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia's CLARITI study results selected for prestigious presentation at the world's largest gastroenterology conference )
Also on site :